{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:55:43Z","timestamp":1790837743109,"version":"4.1.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Scleromyositis (SM), the muscle-specific manifestation of scleroderma, is increasingly recognized as a distinct myositis subset, yet it remains poorly captured by existing classification criteria and absent from therapeutic guidelines. This review provides recent advances in SM with emphasis on challenging presentations and propose a pragmatic diagnostic framework integrating clinical, serological, capillaroscopic, and histopathological data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Recent studies identify capillaropathy as the unifying pathological hallmark of SM across muscle biopsy subtypes. Nailfold videocapillaroscopy reveals a predominantly scleroderma-active or scleroderma-like microangiopathy discriminating SM from potential myositis mimickers. Recent cohort studies demonstrate that SM confers independent mortality burden and substantial cardiac risk warranting immediate cardiac evaluation at diagnosis regardless of autoantibody profile or histological pattern. Pericyte dysfunction may link capillaropathy to fibrosis in SM, while autoantibodies appear to directly disrupt intracellular pathways, contributing to the shared vasculopathic and profibrotic signature that defines SM as a distinct entity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>SM represents a clinically severe and underrecognized disease spectrum that frequently escapes current classification frameworks. Early SM diagnosis requires systematic integration of clinical, serological, capillaroscopic, and histopathological data, with capillaropathy as the unifying thread. Establishing a consensus SM definition and securing clinical trial inclusion remain the most urgent research priorities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001187","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:00:19Z","timestamp":1788336019000},"page":"470-480","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering scleromyositis: no myth, just missed"],"prefix":"10.1097","volume":"38","author":[{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Centre hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Giannini","sequence":"additional","affiliation":[{"name":"Division of Physiology and Muscle Function Explorations, National Reference Center for Systemic Autoimmune Diseases, Strasbourg University Hospital, Strasbourg; UR3072, Research Centre in Biomedicine of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Gyger","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ellezam","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Centre Hospitalier Universitaire Ste-Justine, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"102126","DOI":"10.1016\/j.berh.2026.102126","article-title":"Scleromyositis \u2013 the new frontier","volume":"40","author":"Hudson","year":"2026","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1422.029","article-title":"Systemic sclerosis-associated myopathy","volume":"1108","author":"Ranque","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"e001357","DOI":"10.1136\/rmdopen-2020-001357","article-title":"Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies","volume":"6","author":"Landon-Cardinal","year":"2020","journal-title":"RMD Open"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-025-03662-0","article-title":"Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive study","volume":"27","author":"Shen","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/acr.25672","article-title":"Systemic sclerosis-associated myopathy in a large single-center cohort: autoantibody profiles, histologic features, and independent risk of death","volume":"78","author":"Paik","year":"2026","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/rheumatology\/keab492","article-title":"Autoantibody profiles delineate distinct subsets of scleromyositis","volume":"61","author":"Leclair","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"e003081","DOI":"10.1136\/rmdopen-2023-003081","article-title":"In inflammatory myopathies, dropped head\/bent spine syndrome is associated with scleromyositis: an international case-control study","volume":"9","author":"Pijnenburg","year":"2023","journal-title":"RMD Open"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1212\/NXI.0000000000000694","article-title":"Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis","volume":"7","author":"Su\u00e1rez-Calvet","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"e006495","DOI":"10.1136\/rmdopen-2025-006495","article-title":"Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology","volume":"12","author":"Batani","year":"2026","journal-title":"RMD Open"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/acr.23291","article-title":"Association of fibrosing myopathy in systemic sclerosis and higher mortality","volume":"69","author":"Paik","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.22163","article-title":"Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement","volume":"66","author":"Kaji","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"103608","DOI":"10.1016\/j.autrev.2024.103608","article-title":"Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop","volume":"23","author":"Andrade","year":"2024","journal-title":"Autoimmun Rev"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3899\/jrheum.131450","article-title":"Autoantibodies to the Rpp25 component of the Th\/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests","volume":"41","author":"Mahler","year":"2014","journal-title":"J Rheumatol"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.63032\/JRLV5483","article-title":"Nailfold capillaroscopy in idiopathic inflammatory myopathies","volume":"5","author":"Pinto Oliveira","year":"2026","journal-title":"ARP Rheumatol"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"974078","DOI":"10.3389\/fimmu.2022.974078","article-title":"Scleromyositis: a distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis","volume":"13","author":"Giannini","year":"2022","journal-title":"Front Immunol"},{"key":"R20-20261001","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J Rheumatol"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/key257","article-title":"Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies","volume":"58","author":"Kubo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/ard.2009.115568","article-title":"Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study","volume":"69","author":"Smith","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s10067-019-04716-w","article-title":"Nailfold capillaroscopy in rheumatology: ready for the daily use but with care in terminology","volume":"38","author":"Cutolo","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2010.104","article-title":"Assessing microvascular changes in systemic sclerosis diagnosis and management","volume":"6","author":"Cutolo","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"keaf672","DOI":"10.1093\/rheumatology\/keaf672","article-title":"Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry","volume":"65","author":"De Angelis","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"keaf594","DOI":"10.1093\/rheumatology\/keaf594","article-title":"Nailfold videocapillaroscopy abnormalities in autoimmune inflammatory myopathy subsets","volume":"65","author":"Leclair","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-025-03532-9","article-title":"Nailfold videocapillaroscopy findings are associated with IIM subtypes and IFN activation","volume":"27","author":"Tang","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0738-081X(92)90091-C","article-title":"Scleroderma\/polymyositis overlap syndromes and their immunologic markers","volume":"10","author":"Jablonska","year":"1992","journal-title":"Clin Dermatol"},{"issue":"(Suppl 9)","key":"R29-20261001","article-title":"Transcriptomic profiles in muscle biopsies from systemic sclerosis patients with different autoantibodies [abstract]","volume":"75","author":"Casal-Dominguez","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nmd.2022.12.001","article-title":"Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis","volume":"33","author":"Meyer","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"e12840","DOI":"10.1111\/nan.12840","article-title":"Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis","volume":"48","author":"Ellezam","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"102851","DOI":"10.1016\/j.autrev.2021.102851","article-title":"Histopathological features of systemic sclerosis-associated myopathy: a scoping review","volume":"20","author":"Lefebvre","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/brain\/97.1.115","article-title":"Morphometric study of the muscle microvasculature","volume":"97","author":"Jerusalem","year":"1974","journal-title":"Brain mars"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-021-02305-3","article-title":"Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology","volume":"141","author":"Siegert","year":"2021","journal-title":"Acta Neuropathol"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/ard.2008.095919","article-title":"A descriptive and prognostic study of systemic sclerosis-associated myopathies","volume":"68","author":"Ranque","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/acr.22620","article-title":"Spectrum of muscle histopathologic findings in forty-two scleroderma patients with weakness","volume":"67","author":"Paik","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"(SI)","key":"R37-20261001","doi-asserted-by":"crossref","first-page":"SI82","DOI":"10.1093\/rheumatology\/keac361","article-title":"Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort","volume":"62","author":"Matas-Garc\u00eda","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R38-20261001","author":"De Lorenzis","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R39-20261001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00401-024-02765-3","article-title":"Anti-Ku\u2009+\u2009myositis: an acquired inflammatory protein-aggregate myopathy","volume":"148","author":"Holzer","year":"2024","journal-title":"Acta Neuropathol"},{"key":"R40-20261001","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.70057","article-title":"Immune-mediated necrotizing myopathy overlapping with anti-RuvBL1\/2 antibody-positive systemic sclerosis","volume":"53","author":"Isobe","year":"2026","journal-title":"J Dermatol"},{"key":"R41-20261001","doi-asserted-by":"crossref","first-page":"e70113","DOI":"10.1002\/acr2.70113","article-title":"Anti-RuvBL1\/2 antibodies in scleromyositis: a clinicopathological report of two cases","volume":"7","author":"Imai","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"R42-20261001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00401-026-03006-5","article-title":"Brachio-cervical inflammatory myopathy: multilevel clinical, histopathological and multiomic analyses of a syndrome variably associated with systemic sclerosis","volume":"151","author":"Kleefeld","year":"2026","journal-title":"Acta Neuropathol"},{"key":"R43-20261001","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ajpath.2024.02.021","article-title":"TGF-\u03b21 drives integrin-dependent pericyte migration and microvascular destabilization in fibrotic disease","volume":"194","author":"Pellowe","year":"2024","journal-title":"Am J Pathol"},{"key":"R44-20261001","doi-asserted-by":"crossref","first-page":"110010","DOI":"10.1016\/j.isci.2024.110010","article-title":"Transcriptomic characterization of lung pericytes in systemic sclerosis-associated pulmonary fibrosis","volume":"27","author":"Renaud","year":"2024","journal-title":"iScience"},{"key":"R45-20261001","first-page":"120","article-title":"Enhanced fibrogenic pathways define scleromyositis within the spectrum of EULAR\/ACR myositis subsets [abstract]","volume":"44","author":"Giannini","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"R46-20261001","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/ard-2024-225773","article-title":"Pathological autoantibody internalisation in myositis","volume":"83","author":"Pinal-Fernandez","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R47-20261001","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.ard.2025.04.027","article-title":"In immune-mediated necrotising myopathy, anti-HMGCR antibodies inhibit HMGCR activity, leading to the sarcoplasmic accumulation of lipid droplets and myofibres necrosis","volume":"84","author":"Giannini","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"R48-20261001","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/j.1460-2075.1995.tb07057.x","article-title":"Purification of the sequence-specific transcription factor CTCBF, involved in the control of human collagen IV genes: subunits with homology to Ku antigen","volume":"14","author":"Genersch","year":"1995","journal-title":"EMBO J"},{"key":"R49-20261001","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1080\/15548627.2019.1710430","article-title":"DNA-dependent protein kinase regulates lysosomal AMP-dependent protein kinase activation and autophagy","volume":"16","author":"Puustinen","year":"2020","journal-title":"Autophagy"},{"key":"R50-20261001","first-page":"240","article-title":"Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre study","volume":"44","author":"Calhoun","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"R51-20261001","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.43408","article-title":"Identification of risk factors for incident left ventricular systolic dysfunction and predictors of cardiac recovery in patients with systemic sclerosis","volume":"78","author":"Kim","year":"2026","journal-title":"Arthritis Rheumatol"},{"key":"R52-20261001","doi-asserted-by":"crossref","first-page":"e005191","DOI":"10.1136\/rmdopen-2024-005191","article-title":"Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies","volume":"11","author":"Robert","year":"2025","journal-title":"RMD Open"},{"key":"R53-20261001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00296-026-06159-4","article-title":"Myocarditis in idiopathic inflammatory myopathies: serologic and clinical correlates in a single-center registry","volume":"46","author":"\u00c1lvarez-Troncoso","year":"2026","journal-title":"Rheumatol Int"},{"key":"R54-20261001","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/rheumatology\/keae407","article-title":"Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesions","volume":"64","author":"Le Gouellec","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R55-20261001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40674-023-00206-y","article-title":"Systemic sclerosis associated myopathy: how to treat","volume":"9","author":"Selva-O\u2019Callaghan","year":"2023","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"R56-20261001","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","volume":"84","author":"Del Galdo","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"(Suppl 5)","key":"R57-20261001","doi-asserted-by":"crossref","first-page":"v38","DOI":"10.1093\/rheumatology\/kex196","article-title":"Muscle involvement in systemic sclerosis: points to consider in clinical trials","volume":"56","author":"Walker","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R58-20261001","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G","article-title":"Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients","volume":"43","author":"Poormoghim","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R59-20261001","doi-asserted-by":"crossref","first-page":"23971983251374385","DOI":"10.1177\/23971983251374385","article-title":"Criteria for defining and dating onset of organ system involvement in systemic sclerosis","volume":"10","author":"Hudson","year":"2025","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:02:04Z","timestamp":1790834524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001187","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}